Peter Bell

Integrated BioTherapeutics (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia”.

Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2021.04.017

N/A

0DataRank · unranked

26 citations

Ilayaraja Muthuramu, Suryanarayan Somanathan, Hong Zhang, Peter Bell, Zhenning He +5 more

Immune transgene-dependent myocarditis in macaques after systemic administration of adeno-associated virus expressing human acid alpha-glucosidase

Frontiers in Immunology(2023)10.3389/fimmu.2023.1094279

N/A

0DataRank · unranked

21 citations

Ali Ramezani, Steve Tuske, Nickita Mehta, Chunjuan Song, Anna Lynch +10 more